Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1994-12-22
1998-10-06
Elliot, George C.
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
4353201, 435325, 435366, 424 932, C12N 1586, C12N 510, C12N 508
Patent
active
058174915
ABSTRACT:
An enveloped vector particle contains gag and pol proteins from a retrovirus, a nucleic acid sequence and an envelope that includes VSV G envelope glycoprotein. The vector particle can be used to introduce nucleic acids into cells.
REFERENCES:
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4708818 (1987-11-01), Montagnier et al.
patent: 4725669 (1988-02-01), Essex et al.
patent: 4861719 (1989-08-01), Miller
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 4980289 (1990-12-01), Temin et al.
patent: 5081029 (1992-01-01), Zarling et al.
Adam, M.A. and Miller, D.A., "Identification of a Signal in a Murine Retrovirus That is Sufficient for Packaging of Nonretroviral RNA into Virions", J. Virology 62(10):3802-3806 (1988).
Aldovini, A. and Young, R.A., Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines, Nature 351:479-482 (1991).
Altmann, D.M. et al., "Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells", Nature 338:512-514 (1989).
Ameisen, J.C. and Capron, A., "Cell dysfunction and delpetion in AIDS: the programmed cell death hypothesis", Immunol. Today 12:102-105 (1991).
Anderson, K.D. et al., "Gene expression in implanted rat hepatocytes following retroviral-mediated gene transfer", Somat Cell Mol. Genet. 15:215-227 (1989).
Anderson, W.F. "Prospects for human gene therapy", Science 226:401-409 (1984).
Armentano, D. et al., "Effect of internal viral sequences on the utility of retroviral vectors", J. Virol. 61:1647-1650 (1987).
Arnold et al., J. Cell Biochem. L401:145 (1990).
Baltimore, D., "Gene therapy. Intracellular immunization", Nature 335:395-396 (1988).
Ban et al., "Bovine Leukaemia Virus Packaging Cell Line for Retrovirus-Mediated Gene Transfer", J. Gen. Virol. 70:1987-1993 (1989).
Barnd, D.L. et al., "Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells", Proc. Natl. Acad. Sci. USA 86:7159-7163 (1989).
Baskin, Y., The Gene Doctors, Medical Genetics at the Frontier Genetics at the Frontier William Morrow & Co. N.Y. p. 211 (1984).
Bastin et al., Journal of Experimental Medicine 165:1508-1523 (1987).
Bender, et al. J. Virology 61:1639-1646 (1987).
Berkner, "Development of adenovirus vectors for the expression of heterologous genes", Biotechniques 6:616-629 (1988).
Bernards, R. et al., "N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma", Cell 47:667-674 (1986).
Bernards, R. et al., "Effective tumor immunotherapy directed against an oncogene-encode product using a vaccinia virus vector", Proc. Natl. Acad. Sci. USA 84:6845-6858 (1987).
Besmer et al., "Mechanism of Restriction of Ecotropic and Xenotropic Murine Leukemia Viruses and Formation of Pseudotypes Between the Two Viruses", J. Virology 21(3):965-973 (1977).
Bix et al., Nature 349:329-331 (1991).
Bjorkman, P.J. et al., "The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens", Nature 329:512-518 (1987).
Bolognesi, D.P. and Fischinger, P.J., "Prospects for treatment of human retrovirus-associated diseases", Cancer Res. 45:4700s-4705s, (1985).
Braakman et al., Int. J. Cancer 46:475-480, (1990).
Braciale, T.J. et al., "Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes", Immunol. Rev. 98:95-114 (1987).
Braciale, T.J. and Yap, K.L., "Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells", J. Exp. Med. 147:1236-1252 (1978).
Bubenik, J. et al., "Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumors in nu
u mice", Immunol. Lett. 19:279-282 (1988).
Carey, Business Week pp. 133, 136 (May 1, 1989).
Carr, F. et al., "Genetic transformation of murine bone marrow cells to methotrexate resistance", Blood 62:180-185 (1983).
Cepko, C.L. et al., "Construction and applications of a highly transmissible murine retrovirus shuttle vector", Cell 37:1053-1062 (1984).
Cepko C., "Retrovirus vectors and their applications in neurobiology", Neuron 1:345-353 (1988).
Chakrabarti, S. et al., "Expression of the HTLV-III envelope gene by a recombinant vaccinia virus", Nature 320:535-537 (1986).
Cline et al., "Gene transfer in intact animals", Nature 284:422-425 (1980).
Collins, M.K. et al., "Transfer of functional EGF receptors to an IL3-dependent cell line", J. Cell. Physiol. 137:293-298 (1988).
Cone, et al., "HLA-DR gene expression in a proliferating human thyroid cell clone (12S)", Endocrinology 123:2067-2074 (1988).
Cone, R.D. and Mulligan, R.C., "High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammmalian host range", Proc. Nat. Acad. Sci. USA 81:6349-6353 (1984).
Cortes et al., J. Surg. Onco. 25:289-295 (1984).
Crowley, N.J. et al., "Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogenic melanomas", Cancer Res. 50:492-498 (1990).
Culliton, B.J. "Designing cells to deliver drugs", Science 246:746-751 (1989).
Dallo, S. et al., "Humoral immune response elicited by highly attenuated variants of vaccine virus and by an attenuated recombinant expressing HIV-1 envelope protein", Virology 173:323-329 (1989).
Danos et al., "Safe and Efficient Generation of Recombinant Retroviruses with Amphotropic and Ecotropic Host Ranges", Proc. Natl. Acad. Sci., USA 85:6460-6464 (1988).
De Baetselier, P. et al., "Differential expression of H-2 gene products in tumor cells in associated with their metastatogenic properties", Nature 288:179-181 (1980).
Delouis et al., "Xenotropic and Amphotropic Pseudotyped Recombinant Retrovirus to Transfer Genes into Cells from Various Species", Biochem. Biophys. Res. Comm. 169(1):8-14 (1990).
de Vries, J.E. et al., "Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes", Immunol. Rev. 109:119-141 (1989).
Dewar, R.L. et al., "Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus", J. Virol. 63:129-136 (1989).
Earl et al., J. Virol. 65:31-41 (1991).
Ellrodt et al., Nature 325:765, (1987).
Embertson, J.E. and Temin, H.M., "Pseudotyped Retroviral Vectors Reveal Restrictions to Reticuloendotheliosis Virus Replication in Rat Cells", J. Virol. 60:662-668 (1986).
Embertson et al. J. Virology 61:2675-2683 (1987).
Emi et al., J. Cell Biochem. Supl. 14A:367, Abstract D408.
Emi, N. et al. "Pseudotype Formation of Murine Leukemia Virus with the G Protein of Vesicular Stomatitis Virus", Journal of Virology, 65(3):1202-1207 (1991).
Epsikopou et al., PNAS 81:4657-4661 (1984).
Estin et al., PNAS 85:1052-1056 (1988).
Evans et al., Nature 339:385-388 (1989).
Faraji-Shaden et al., Medical Hypothesis 32:81-84 (1990).
Fauci et al., Ann Intern. Med. 110:373-385 (1989).
Flexner et al., Virology 166:339-349 (1988).
Friedmann, Ann. N.Y. Acad. Sci. 265:141-152 (1975).
Friedmann, Science 244:1275-1281 (1989).
Gansbacher et al., Cancer Research 50:7820-7825 (1990).
Gattoni-Celli et al., PNAS 85:8543-8547 (1988).
Gilboa et al., BioTechniques 4:504-512 (1986).
Gilboa et al., The Biology of Hematopiesis pp. 301-311 (1990).
Graham et al., Virology 52:456-457 (1973).
Gruber et al., Science 230:1057-1061 (1985).
Guarini et al., Cancer Immunol. Immunother. 30:262-268 (1989).
Hatzoglou et al., J. Biol. Chem. 263:17798-17808 (1988).
Haynes et al., Science 260:1279-1286 (1993).
Hellerman et al., PNAS 81:5340-5344 (1984).
Hester et al., J. Nat. Cancer Inst. 82:1209-1214 (1990).
Hickling et al., Journal of Virology 61:3463-3469 (1987).
Hoffenbach et al., Journal of Immunology 142:452-462 (1989).
Hopkins, N., "High titers of Retrovirus (vesicular stomatitis virus) pseudotypes, at last", Proc. Natl. Acad. Sci. USA 90:8759-8760 (1993).
Hoshino, H. et al., "Human T-cell Leukemia Virus Type I: Pseudotype Neutralization of Japanese and American Isloates with Human and Rabbit Sera", Int. J. Cancer 36:671-
Barber Jack R.
Emi Nobuhiko
Friedmann Theodore
Jolly Douglas J.
Yee Jiing-Kuan
Bozicevic Karl
Chiron Viagene, Inc.
Elliot George C.
Francis Carol
Railey II Johnny F.
LandOfFree
VSV G pseusdotyped retroviral vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VSV G pseusdotyped retroviral vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VSV G pseusdotyped retroviral vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-76014